Disclosures: Dimple Desai: Nothing to Disclose, Rashmee Patil: Akero Therapeutics: Grant/Research Support, Altimmune: Grant/Research Support, 89Bio: Grant/Research Support, Boehringer Ingelheim: Grant/Research Support, Boston Pharmaceuticals: Grant/Research Support, Eli Lilly: Grant/Research Support, Helio Health: Grant/Research Support, Inventiva: Grant/Research Support, Madrigal Pharmaceuticals: Grant/Research Support, Madrigal Pharmaceuticals: Speaking and Teaching, Merck: Grant/Research Support, Novo Nordisk: Grant/Research Support, Novo Nordisk: Consultant, Galectin Therapeutics: Grant/Research Support, Hepion Pharmaceuticals: Grant/Research Support, GlaxoSmithKline: Grant/Research Support, Corcept Therapeutics: Grant/Research Support 899 REAL-WORLD EXPERIENCE WITH FIBROSCAN IN A TRIBAL SPECIALTY LIVER CLINIC Janet Johnston 1 Youssef Barbour 2 Lisa Townshend-Bulson 3 Chriss Homan 2 Kena Desai 2 Wileina Rhodes 2 Julia Plotnik 2 Jennifer Gantz 2 Brian McMahon 4 , 1 Alaska Native Tribal Health Consortiu, 2 Alaska Native Tribal Health Consortium, 3 Alaska Native Tribal Consortium, 4 Alaska Native Medical Center Background: The Liver Disease and Hepatitis Program (LDHP) at the Alaska Native Tribal Health Consortium provides specialty liver care to Alaska Native and American Indian (AN/AI) peoples
Copper peptides (GHK-Cu): the strongest evidence base in the cosmetic peptide world, with the heaviest data in wound-healing adjacent applications, not the "smooth out your fine lines" use case they get sold for
An autoimmune-induced formation of antibodies, i.e
The capsules are very easy to take and caused no adverse effects
2 Method 2.1 Eligibility criteria for participants A database search using The Clinics Electronic Health Records (EHR) system was completed extrapolating patient medical charts with the diagnosis of PD and undergoing treatment between the dates of January 1, 2018, and March 6, 2020
Cunningham, B
